Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-30
1998-07-07
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514327, A61K 3144, A61K 31445
Patent
active
057769567
ABSTRACT:
A pharmaceutical composition is provided that is useful in treating obsessive-compulsive disorder, Tourette's Syndrome and schizophrenia comprising an amount of cotinine or a pharmaceutically acceptable salt thereof, which amount is effective to reduce or alleviate at least one of the symptoms of Tourette's Syndrome, obsessive-compulsive disorder, or schizophrenia in a human or other mammal.
REFERENCES:
patent: 3870794 (1975-03-01), Hutchinson et al.
patent: 4946853 (1990-08-01), Bannon et al.
patent: 5187169 (1993-02-01), Lippiello et al.
patent: 5298257 (1994-03-01), Bannon et al.
patent: 5596007 (1997-01-01), Keenan et al.
patent: 5612357 (1997-03-01), Keenan et al.
patent: 5643928 (1997-07-01), Keenan
Freedman, R., Hall M., Adler L.E., Leonard S. "Evidence of Postmortem Brain Tissue for Decreased Number of Hippocumpal Nicotinic Receptors in Schizophrenia." Biol. Psychiatry 38(1):22-33 (1995).
Newhouse PA, Potter A, Corwin J, Lenox R. "Age-Related Effects of the Nicotine Antagonist Mecamylamine on Cognition and Behavior." Neuropsychopharmacology 10(2):93-107 (1994).
McConville BJ, Sanberg PR, Fogelson MH, et al. "The Effects of Nicotine Plus Haloperidol Compared to Nicotine Only and Placebo Nicotine Only in Reducing Tlc Severity and Frequency in Tourette's Disorder." Biol. Psychiatry 31(8):832-840 (1992).
Rosecrans JA. "The Role of Nicotine in Tobacco Dependence and Cessation". Chemistry & Industry. pp. 221-224 (Mar. 21, 1994).
Harmon James V.
LecTec Corporation
Spivack Phyllis G.
LandOfFree
Use of cotinine in treating psychiatric disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cotinine in treating psychiatric disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cotinine in treating psychiatric disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206346